Fortress Biotech (FBIO) Tops Q1 EPS by 60c, Slight Beat on Revenues

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 11/4/2026

1. AMD
2. BKNG
3. AMGN
4. DOX
5. DUOL
6. SWKS
7. ANET
8. SPY
9. XYZ
10. CVS

Go back to Fortress Biotech (FBIO) Tops Q1 EPS by 60c, Slight Beat on Revenues

Mustang Bio Reports First Quarter 2019 Financial Results and Recent Corporate Highlights

May 10, 2019 7:32 AM EDT

NEW YORK, May 10, 2019 (GLOBE NEWSWIRE) -- Mustang Bio, Inc. (Mustang) (NASDAQ: MBIO), a clinical-stage biopharmaceutical company focused on translating todays medical breakthroughs in cell and gene therapies into potential cures for hematologic cancers, solid tumors and rare genetic diseases, today announced financial results and recent corporate highlights for the first quarter ended March 31, 2019.

Manuel Litchman, M.D., President and Chief Executive Officer of Mustang, said, The beginning of 2019 has been an exciting time for Mustang and provides great momentum for the rest of the year. Last month, we... More